Physician profile
Jason B Pulliam
NPI 1164453452
$1,294.80
in general payments reported to CMS, 2019-2025
16 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.27 · 2020: $172 · 2021: $200 · 2022: $189 · 2023: $328 · 2024: $36.89 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $329.71 | 2022-2025 | Infuse, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $237.15 | 2019-2021 | |
| Lkc Technologies, INC. | $120.27 | 2023 | |
| Novartis Pharmaceuticals Corporation | $93.90 | 2022-2023 | |
| Alcon Vision LLC | $90.20 | 2021-2024 | Total30 |
| Biotissue Holdings INC. | $84.51 | 2021-2023 | |
| Allergan, INC. | $67.01 | 2020-2022 | |
| Coopervision INC. | $57.62 | 2021-2025 | Myday Contact Lens |
| Topcon Healthcare, INC. | $47.36 | 2020 | |
| Harrow Eye, LLC | $35.29 | 2025 | Vevye |
| Abbvie INC. | $29.49 | 2022 | |
| Maculogix, INC. | $24.79 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $21.98 | 2025 | Xdemvy |
| Optos, INC. | $20.86 | 2020 | |
| Shire North American Group INC | $20.28 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $14.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Pulliam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.